Dublin, June 15, 2021 (GLOBE NEWSWIRE) -- The "Global Tissue Engineered Skin Substitutes Market (2021-2026) by Biomaterial, Anatomical Structure, Product Type, Application, Technology, Duration, End-user, Geography, Competitive Analysis and the Impact of COVID-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Tissue Engineered Skin Substitutes Market is estimated to be USD 703.3 million in 2021 and is expected to reach USD 864 million by 2026, growing at a CAGR of 4.2%.
The Global Tissue Engineered Skin Substitutes Market is segmented further based on Biomaterial, Anatomical Structure, Product Type, Application, Technology, Duration, End User, and Geography.
By Biomaterial, the market is classified as autologous, allogeneic, xenogeneic and amnion. Amongst the two, the Autologous segment is estimated to hold the highest market share.
By Anatomical Structure, the market is segmented as Cellular and Acellular. Acellular Anatomical Structure is estimated to hold the highest market share during the forecast period.
By Product Type, the market is classified as Natural and Synthetic. Synthetic products are further segmented as biodegradable and Non-biodegradable. Natural segment holds the highest market share.
By Application, the market is classified as chronic wounds, burns cases, traumatic wounds, diabetic foot ulcers and others. Amongst all, the Chronic Wounds segment is estimated to hold the highest market share.
By Technology, the market is classified as Laser assisted bio-printing, 3D, Robotic Technology, and Others. Amongst them, the 3D Technology is estimated to hold the highest market share.
By Duration, the market is classified as Permanent and Semi-permanent. Amongst the two, the Permanent segment is estimated to hold the highest market share.
By End User, the market is classified as Hospital and Clinic, Ambulatory Surgical Center, and Others. The Hospital and Clinic segment is estimated to hold the highest market share.
By Geography, North America dominates the market.
1. Acelity enters agreement to transition Systagenix manufacturing facility to Scapa Healthcare. - September 2020
2. Integra LifeSciences Announces Definitive Agreement to Acquire ACell, Inc. - December 2020
Some of the companies covered in this report Smith & Nephew, Molnlycke Health Care, Integra LifeSciences, Regenicin., Organogenesis Inc, MiMedx., LifeNet Health, Kerecis, Medline Industries, BSN medical, ConvaTec Group, Mallinckrodt, Tissue Regenix, etc.
The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
The report offers a comprehensive evaluation of the Global Tissue Engineered Skin Substitutes Market.
The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
The report also contains the competitive analysis using Competitive Quadrant, the analyst's proprietary competitive positioning tool.
A complete analysis of the market, including parent industry
Important market dynamics and trends
Historical, current, and projected size of the market based on value and volume
Market shares and strategies of key players
Recommendations to companies for strengthening their foothold in the market
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Overview
4.2 Market Dynamics
188.8.131.52 Increasing Prevalence of Acute and Chronic Wounds
184.108.40.206 Rising Demand for Skin Grafts
220.127.116.11 Rising Awareness Regarding Various Treatment Options
18.104.22.168 Increasing adoption and a suitable alternative to auto- and allografts
22.214.171.124 Rising Incidences of Accidents, such as Road Accidents, Burns, and Trauma
126.96.36.199 Lack of Proper Reimbursement Policies
188.8.131.52 High Cost of Treatment and Prolonged Treatment Time
184.108.40.206 Inability of Biologists, Biochemists, and Technical Engineers to Reproduce Skin Appendages
220.127.116.11 Focus of Researchers on establishing new construction technologies in the arena of skin tissue engineering
18.104.22.168 Difficulty in producing complex skin substitutes that can readily be transplanted in large quantities
22.214.171.124 Issues with the Biomaterials used for skin grafts
126.96.36.199 Challenges in finding a substitute for split-thickness grafts
4.3.1 The 3-D bio textile and bio printing
5 Market Analysis
5.1 Porter's Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis
6 Global Tissue Engineered Skin Substitutes Market, By Biomaterial
7 Global Tissue Engineered Skin Substitutes Market, By Anatomical Structure
8 Global Tissue Engineered Skin Substitutes Market, By Product Type
9 Global Tissue Engineered Skin Substitutes Market, By Application
9.2 Chronic Wounds
9.3 Burns Cases
9.4 Traumatic Wounds
9.5 Diabetic Foot Ulcers
10 Global Tissue Engineered Skin Substitutes Market, By Technology
10.2 Laser assisted bio-printing
10.4 Robotic Technology
11 Global Tissue Engineered Skin Substitutes Market, By Duration
12 Global Tissue Engineered Skin Substitutes Market, By End User
12.2 Hospital and Clinic
12.3 Ambulatory Surgical Centre
13 Global Tissue Engineered Skin Substitutes Market, By Geography
13.2 North America
13.3 South America
13.4.6 Rest of Europe
13.5.6 South Korea
13.5.9 Rest of APAC
13.6 Rest of the World
13.6.2 Saudi Arabia
13.6.3 South Africa
13.6.4 United Arab Emirates
13.6.5 Latin America
14 Competitive Landscape
14.1 Competitive Quadrant
14.2 Market Share Analysis
14.3 Competitive Scenario
14.3.1 Mergers & Acquisitions
14.3.2 Agreement, Collaborations, & Partnerships
14.3.3 New Product Launches & Enhancements
14.3.4 Investments & funding
15 Company Profiles
15.1 Organogenesis, Inc
15.2 Smith & Nephew
15.3 BSN Medical
15.4 Molnlycke Health Care
15.5 Integra LifeSciences
15.7 Tissue Regenix Ltd
15.8 Stratatech (A Mallinckrodt Company)
15.11 LifeNet Health
15.13 Medline Industries, Inc
15.14 ConvaTec Group
15.16 Amarantus Bioscience Holdings
15.17 3M Inc
For more information about this report visit https://www.researchandmarkets.com/r/u9r9uq
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900